TBA Law Blog

Posted by: Brittany Sims on Oct 12, 2012

According to most recent reports, 15 new cases of fungal meningitis were announced today, bringing the nationwide total to 184. As that number continues to grow, a group of plaintiffs have filed the first federal class action suit against the Framingham, Mass., pharmaceutical company alleged to be the source of the contaminated spinal steroids. The suit, filed in a U.S. District Court in Minnesota, charges that the company “had a duty to use reasonable care in designing and manufacturing the methylprednisolone acetate steroid doses such that they are not unreasonably dangerous.” The Tennessean has the story